How CJEU Santen is expected to shape landscape of patent extensions by SPCs
Publications | 17.08.2020
The Court of Justice of the European Union’s (CJEU’s) recently rendered Judgment in Santen v INPI (C-673/18) is expected to shape the landscape of patent extensions by Supplementary Protection Certificates (“SPCs”) more than any other decision of this court over the last 10 years and not to the favor of the researching pharmaceutical industry. It is generally considered a complete reversal of case law which the same court had initiated in 2012 (C-130/11; Neurim Pharmaceuticals (1991) Ltd v Comptroller).
Click here to find our comments on CJEU Santen
Should you have any questions or need more information, please do not hesitate to contact Dr. Klemens Stratmann or Dr. Bianca Vos.